Nanjing Vazyme Biotech Co Ltd (688105) — Free Cash Flow Generation Index

Latest as of September 2025: 0.79x

Nanjing Vazyme Biotech Co Ltd (688105) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥59.46 Million represents 1% of operating cash flow (CN¥75.30 Million). See 688105 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.79x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥59.46 Million
CNY

Operating Cash Flow

CN¥75.30 Million
CNY

Capital Expenditures

CN¥15.83 Million
CNY

Nanjing Vazyme Biotech Co Ltd Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Explore 688105 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Nanjing Vazyme Biotech Co Ltd (2019–2025)

Year-by-year Free Cash Flow Generation Index for Nanjing Vazyme Biotech Co Ltd. For the full company profile including market capitalisation, see 688105 market cap.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.80x CN¥185.77 Million CN¥233.16 Million CN¥47.39 Million ▲ +297.8%
2023 -0.40x CN¥-79.91 Million CN¥198.40 Million CN¥232.90 Million ▼ -30.0%
2022 -0.31x CN¥-227.69 Million CN¥735.17 Million CN¥962.86 Million ▼ -153.8%
2021 0.58x CN¥354.84 Million CN¥616.80 Million CN¥261.96 Million ▼ -29.0%
2020 0.81x CN¥651.01 Million CN¥803.55 Million CN¥152.54 Million ▲ +363.2%
2019 -0.31x CN¥-4.68 Million CN¥15.20 Million CN¥19.88 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).